What are the possible causes of an elevated activated partial thromboplastin time in a 6‑year‑old girl presenting with bruising?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Elevated aPTT in a 6-Year-Old with Bruising: Differential Diagnosis

In a 6-year-old girl presenting with bruising and elevated aPTT, the most likely causes are congenital factor deficiencies (hemophilia A/B, von Willebrand disease, or factor XI deficiency), acquired hemophilia A, lupus anticoagulant, or less commonly contact factor deficiencies—with the clinical presentation of bruising making a true bleeding disorder more probable than an artifact or benign finding.

Algorithmic Approach to Diagnosis

Step 1: Rule Out Pre-analytical Issues

Before pursuing extensive workup, verify the specimen was properly collected 1:

  • Confirm adequate blood-to-anticoagulant ratio (underfilled tubes cause artifactual prolongation)
  • Exclude heparin contamination from IV lines
  • Verify no clotting in the sample
  • Consider reagent-specific age-appropriate reference ranges—critical in pediatrics as approximately 30% of children aged 1-5 years would be misclassified as abnormal using adult reference ranges 1

Step 2: Assess Clinical Bleeding Risk

The presence of bruising significantly increases the likelihood of a true bleeding disorder. A prolonged aPTT with clinical symptoms has a 62% positive predictive value for a bleeding disorder, while absence of symptoms and negative family history yields an 80% negative predictive value 2. Your patient's bruising warrants thorough investigation.

Step 3: Perform Mixing Study

This distinguishes factor deficiency from inhibitors 3:

  • Factor deficiency: aPTT corrects with 1:1 mixing with normal plasma
  • Inhibitor present: aPTT remains prolonged or shows time-dependent prolongation

Step 4: Specific Causes by Category

A. Congenital Factor Deficiencies (Most Common in Pediatrics)

If mixing study corrects, measure specific factors:

  • Hemophilia A (Factor VIII deficiency): Most common severe inherited bleeding disorder
  • Hemophilia B (Factor IX deficiency): Second most common
  • Factor XI deficiency: Variable bleeding tendency
  • von Willebrand disease: Most common inherited bleeding disorder overall, can prolong aPTT when severe

B. Acquired Hemophilia A

Though rare in children, any acute onset bleeding with unexplained isolated prolonged aPTT should prompt consideration of acquired hemophilia A 4. This presents with:

  • Autoantibodies against Factor VIII
  • No previous bleeding history
  • Mixing study shows non-correction (inhibitor pattern)
  • Requires immediate immunosuppressive therapy if diagnosed 4

C. Lupus Anticoagulant/Antiphospholipid Antibodies

  • Paradoxically associated with thrombosis, not bleeding
  • Mixing study shows non-correction
  • Requires specific lupus anticoagulant testing
  • The bruising in your patient makes this less likely as the primary cause

D. Contact Factor Deficiencies (Clinically Benign)

  • Factor XII, prekallikrein, or high molecular weight kininogen deficiency 5, 6
  • Critical distinction: These do NOT cause clinical bleeding despite prolonged aPTT
  • If identified, provides reassurance and avoids unnecessary treatment
  • However, the presence of bruising makes this diagnosis less likely

Key Clinical Pitfalls

Reagent-Specific Pediatric Reference Ranges: The aPTT reference range can either increase or decrease with age depending on the specific reagent used 1. Using inappropriate adult ranges leads to both over-diagnosis and missed diagnoses. Ensure your laboratory uses age-appropriate, reagent-specific reference ranges.

Artifactual Prolongation: In approximately 14% of cases, prolonged aPTT is artifactual 7. Extremely prolonged values (>120 seconds) may actually represent very short clotting times that form before automated instruments begin reading 8.

Clinical Context Trumps Laboratory Values: Among patients with truly abnormal aPTT due to hemostatic defects, 81% had abnormal bleeding history, but 19% did not 7. The degree of aPTT prolongation correlates poorly with actual bleeding risk—the cause matters more than the absolute value 7.

Recommended Workup Sequence

  1. Repeat aPTT with careful attention to collection technique
  2. Mixing study (1:1 with normal plasma, immediate and incubated)
  3. If corrects: Factor VIII, IX, XI, XII levels; von Willebrand panel
  4. If doesn't correct: Lupus anticoagulant testing, Factor VIII inhibitor assay (Bethesda)
  5. If all negative: Contact factor assays (prekallikrein, high molecular weight kininogen)

Given the clinical presentation of bruising in a child, prioritize evaluation for hemophilia A, von Willebrand disease, and factor XI deficiency first, as these represent the most common clinically significant causes in this age group with bleeding manifestations.

References

Related Questions

What symptoms should I ask the patient about to evaluate a prolonged activated partial thromboplastin time?
How should I work up an asymptomatic middle-aged man with a prolonged activated partial thromboplastin time greater than twice the upper limit?
Is an activated partial thromboplastin time of 39 seconds significant in a woman who is not on anticoagulants or supplements and was menstruating at the time of testing?
When is fresh frozen plasma indicated to correct prolonged prothrombin time/international normalized ratio (PT/INR) or activated partial thromboplastin time (aPTT) abnormalities?
In a patient with malignant cerebrovascular infarct and heart failure who is not on antiplatelet or anticoagulant therapy and has an activated partial thromboplastin time of ~36 seconds, a prothrombin time of 13.8 seconds, and an INR of 1.2, what should be given to correct coagulation prior to tracheostomy?
What is the optimal daily iodine intake for a healthy adult population to optimize health?
How should bacterial conjunctivitis be treated if tobramycin eye drops are ineffective?
What is the Xigduo (dapagliflozin 5 mg/metformin 500 mg) equivalent of Synjardy (empagliflozin 5 mg/metformin 500 mg) taken twice daily?
In a 25-year-old woman with mild leukopenia, low‑normal absolute neutrophil count, borderline low absolute lymphocyte count, and mildly elevated mean corpuscular volume, what is the differential diagnosis and what laboratory studies and management steps should be pursued?
Can heparin-induced thrombocytopenia (HIT) develop after prior heparin exposure, or does it only occur on the first exposure?
Which electrolytes are most affected by red‑cell hemolysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.